Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Quest Diagnostics Incorporated DGX

Healthcare  —  Diagnostics & Research
236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

 22.06 19.56 21.37 22.22
P/S ratio 1.97 1.75 1.91 2.04
P/FCF ratio 15.32 14.17 16.26 17.44
P/Operating CF 37.91 41.42 77.55 39.41
P/B ratio 2.93 2.67 2.81 3.01
Price to Tangible BV 0.00 0.00 0.00 0.00
EV/Sales 2.45 2.22 2.38 2.47
EV/EBITDA 12.72 11.53 12.27 12.92
EV/Operating CF 14.11 13.00 14.50 15.00
EV/FCF 19.09 18.04 20.23 21.16
Quick Ratio 0.88 0.80 0.91 1.28
Current Ratio 1.13 1.04 1.18 1.59
Net Debt/EBITDA 9.93 9.89 9.64 8.29
Debt/Assets 35.04% 34.95% 33.94% 33.31%
Debt/Equity 0.78 0.79 0.74 0.72
Asset Turnover 0.67 0.68 0.69 0.70
Operating CF/Net income 2.30 1.93 1.10 1.87
Capex/Depreciation (1.01) (1.09) (0.78) (0.95)
Interest Coverage 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 17.79% 17.96% 17.41% 17.38%
Intangible Assets out of Total Assets 0.65 0.65 0.65 0.64
Share Based Compensation of Revenue 0.71% 0.89% 0.69% 0.76%
Graham Net Nets (0.30) (0.34) (0.30) (0.27)
Graham Number 112.53 113.83 119.91 122.96
Earnings Yield 4.53% 5.11% 4.68% 4.50%
Free Cash Flow Yield 6.53% 7.06% 6.15% 5.73%
Revenue per Share 25.14 25.28 26.32 27.41
Operating CF per Share 5.03 4.19 2.53 5.38
Capex per Share (1.29) (1.42) (1.04) (1.24)
Free Cash Flow per Share 3.74 2.77 1.49 4.14
Cash per Share 3.86 3.78 3.57 5.64
Shareholders Equity per Share 65.13 64.92 69.69 70.44
Interest Debt per Share 0.00 0.00 0.00 0.00
Book value per Share 65.13 64.92 69.69 70.44
Free Cash Flow 419.00 307.00 164.00 459.00
Working Capital 273.00 100.00 389.00 1,056.00
Capital Expenditures (144.00) (158.00) (114.00) (138.00)
Net Current Asset Value (6,495.00) (6,641.00) (6,441.00) (6,276.00)
EV/EBIT 17.37 15.75 16.67 17.51
Capex to Sales 0.05 0.06 0.04 0.05
Net Profit Margin 8.70% 8.59% 8.70% 10.52%
Price to Operating Income 13.94 12.38 13.40 14.43
Other line items
Average Receivables 1,416.00 1,356.00 1,495.50 1,542.50
Average Payables 1,385.00 1,497.00 1,383.50 1,473.50
Average Inventory 185.00 188.50 207.00 210.00
Average Assets 16,146.00 16,189.00 16,235.00 16,454.00
Average Common Equity 7,068.00 7,009.50 7,314.00 7,542.00

Fold the line items

Columns are period end dates